Article
Refine
Document Type
- Article (9) (remove)
Language
- English (9)
Has Fulltext
- yes (9)
Is part of the Bibliography
- no (9)
Keywords
- - (5)
- 3,5-Diiodothyronine (1)
- Iodine (1)
- MRI (1)
- Measurement error (1)
- NAFLD (1)
- NMR spectroscopy (1)
- TSH (1)
- Thyroglobulin (1)
- Thyroid (1)
- Thyroid hormone (1)
- Thyroid imaging (1)
- Thyroid-stimulating hormone (1)
- Trigonelline (1)
- Urine metabolome (1)
- Variability (1)
- anthropometry (1)
- area deprivation (1)
- blood count (1)
- body weights and measures (1)
- cortisol (1)
- diagnostic techniques and procedures (1)
- education (1)
- fT3 (1)
- fT4 (1)
- hepatic steatosis (1)
- income (1)
- lipid profile (1)
- longitudinal cohort study (1)
- macrovascular disease (1)
- mediation (1)
- metabolic syndrome (1)
- metabolome (1)
- obesity (1)
- oral contraceptives (1)
- phenotyping (1)
- population-based imaging (1)
- population-based studies (1)
- radiomics (1)
- spleen volume (1)
- thyroid (1)
- whole-body magnetic resonance imaging (1)
Institute
- Institut für Community Medicine (9) (remove)
Publisher
- MDPI (3)
- S. Karger AG (2)
- BioScientifica (1)
- Frontiers Media S.A. (1)
- Nature Publishing Group (1)
- Upsala Medical Society (1)
Context: 3,5-Diiodo-<smlcap>L</smlcap>-thyronine (3,5-T<sub>2</sub>) is a thyroid hormone metabolite which exhibited versatile effects in rodent models, including the prevention of insulin resistance or hepatic steatosis typically forced by a high-fat diet. With respect to euthyroid humans, we recently observed a putative link between serum 3,5-T<sub>2</sub> and glucose but not lipid metabolism. Objective: The aim of the present study was to widely screen the urine metabolome for associations with serum 3,5-T<sub>2</sub> concentrations in healthy individuals. Study Design and Methods: Urine metabolites of 715 euthyroid participants of the population-based Study of Health in Pomerania (SHIP-TREND) were analyzed by <sup>1</sup>H-NMR spectroscopy. Multinomial logistic and multivariate linear regression models were used to detect associations between urine metabolites and serum 3,5-T<sub>2</sub> concentrations. Results: Serum 3,5-T<sub>2</sub> concentrations were positively associated with urinary levels of trigonelline, pyroglutamate, acetone and hippurate. In detail, the odds for intermediate or suppressed serum 3,5-T<sub>2</sub> concentrations doubled owing to a 1-standard deviation (SD) decrease in urine trigonelline levels, or increased by 29-50% in relation to a 1-SD decrease in urine pyroglutamate, acetone and hippurate levels. Conclusion: Our findings in humans confirmed the metabolic effects of circulating 3,5-T<sub>2</sub> on glucose and lipid metabolism, oxidative stress and enhanced drug metabolism as postulated before based on interventional pharmacological studies in rodents. Of note, 3,5-T<sub>2</sub> exhibited a unique urinary metabolic profile distinct from previously published results for the classical thyroid hormones.